M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Cash from Financing Activities
zł596.7k
CAGR 3-Years
N/A
CAGR 5-Years
127%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Cash from Financing Activities
zł895k
CAGR 3-Years
-29%
CAGR 5-Years
38%
CAGR 10-Years
33%
R
Ryvu Therapeutics SA
WSE:RVU
Cash from Financing Activities
zł91.7m
CAGR 3-Years
N/A
CAGR 5-Years
41%
CAGR 10-Years
26%
S
Selvita SA
WSE:SLV
Cash from Financing Activities
-zł50.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Cash from Financing Activities?
Cash from Financing Activities
596.7k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Cash from Financing Activities amounts to 596.7k PLN.

What is Medicofarma Biotech SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
127%

Over the last year, the Cash from Financing Activities growth was -12%.

Back to Top